MicroRNA-19b is a potential biomarker of ... - Semantic Scholar
Recommend Documents
May 1, 2012 - 1 Division of Experimental Therapeutics, Toronto General Hospital Research Institute, University Health Network, Toronto, Ontario, Canada, ...
Jun 29, 2017 - of New Jersey, United States. Federica Barbieri, .... To generate wild-type BRCA1-expressing HCC1937 cells, naà¹ve. HCC1937 cells were ...
Oct 13, 2010 - haptoglobin, serotransferrin, CD5 antigen like protein, clusterin, apolipoprotein and leucine-rich alpha-2- glycoprotein. For the discrimination of ...
Jun 25, 2016 - measurements of heavy metals in different parts of the plant, such as its ..... Fossi, M.C. The role of biomarkers in environmental assessment (2).
Jan 12, 2017 - Early blood brain barrier (BBB) damage is the major risk factor for ..... Images were captured on a fluorescence microscope (Olympus IX71).
Dec 18, 2015 - J Hepatol. 2015 Apr; 62. (4):841â7. doi: 10.1016/j.jhep.2014.11.024 PMID: 25433159. 21. Salama SM, Bilgen M, Al Rashdi AS, Abdulla MA.
in type 2 diabetes: the Casale Monferrato Study. Diabetes 2009;58:926â933. 14. Ridker PM. C-reactive protein: eighty years from discovery to emergence.
Cancer. Mary Ann Sens,1 Seema Somjii2 Donald L. Lamm,2 Scoff H. Garrett,2 Frank Slovinsky,1 John H. Todd,1 and Donald. A. SenS2. 1Robert C. Byrd Health ...
hydroxychloroquine (mean dosage 333.3 mg/d), 13 with azathioprine (mean dose 95.5 mg/d) and four patients were receiving mycophenolat mofetil (mean dose.
oestrogen, and its induction was inhibited by antioestrogens, tamoxifen, 4-hydroxytamox- ifen and fulvestrant in oestrogen-responsive breast cancer cells.
Two recently approved drugs, pirfenidone (Esbriet; Genentech, San Francisco, CA,. USA) and nintedanib (Ofev; Boehringer Ingelheim, Ingelheim, Germany), ...
CD44v9. (+). GTPase activating protein binding protein 1. G3BP1. 14 916 572. â. 3.14. N. T, ST. RAB35, member RAS oncogene family. RAB35. Q15286. â. 1.71.
Feb 7, 2018 - 0.001) and SOFA (P = 0.04) scores, suggesting that phosphate ... Approximately 5% of patients .... Continuous variables with normal distribution were expressed as the mean ± standard deviation and compared using the Student's t-test or
in a murine model of uterine sarcoma, Reprimo was signifi- cantly increased in normal uteri of p53 wild-type mice, but. Reprimo expression was not increased in ...
... July 2012; accepted 19 July 2012; online publish-ahead-of-print 31 August 2012 ... non-fatal stroke), 96 cases of new-onset renal impairment, and 220 deaths.
G-protein-coupled receptor kinase-interacting protein 1 (GIT1) was originally considered as a ...... Collagen triple helix repeat containing. 1 (CTHRC1) acts via ...
Mar 12, 2014 - personalized therapies. Nevertheless, in vivo and in .... Software, Inc. [www.graphpad.com]) and SPSS version 21 (SPSS. Inc, Chicago, Illinois).
Dec 24, 2014 - J. Biol. Chem. 273:13280â13288. 13. Bhatt, K. V., L. S. Spofford, G. Aram, M. McMullen, K. Pumiglia, and A. E. Aplin. 2005. Adhesion control of.
Apr 25, 2017 - Department of Medical Imaging, The Second Affiliated Hospital, Medical College of Shantou University, Shantou 515041,. China. 2.
Mar 12, 2014 - Tian Gao1, Yong Han2, Ling Yu3, Sheng Ao1, Ziyu Li1, Jiafu Ji1*. 1 Key Laboratory of Carcinogenesis and Translational Research Ministry of ...
6Department of Surgery, Samsung Medical Center, ..... S3). High mRNA levels of AROS are associated with tumor stage, BCLC stage, AFP level, vascular ...
Feb 26, 2014 - of cervical intraepithelial neoplasia (CIN) 2 outcome in women with a cervical smear showing a low-grade squamous intraepithelial lesion ...
Jan 27, 2014 - bAckground: Levothyroxine (LT4) therapy has shown to have effects on bone metabolism though its deleterious effect on bone remodeling is ...
MicroRNA-19b is a potential biomarker of ... - Semantic Scholar
received: 29 June 2016 accepted: 08 December 2016 Published: 16 January 2017
MicroRNA-19b is a potential biomarker of increased myocardial collagen cross-linking in patients with aortic stenosis and heart failure Javier Beaumont1,2,*, Begoña López1,2,*, Susana Ravassa1,2, Nerea Hermida3, Gorka San José1,2, Idoia Gallego1,2, Félix Valencia4, Juan José Gómez-Doblas4, Eduardo de Teresa4, Javier Díez1,2,5 & Arantxa González1,2 This study analyzed the potential associations of 7 myocardial fibrosis-related microRNAs with the quality of the collagen network (e.g., the degree of collagen fibril cross-linking or CCL) and the enzyme lysyl oxidase (LOX) responsible for CCL in 28 patients with severe aortic stenosis (AS) of whom 46% had a diagnosis of chronic heart failure (HF). MicroRNA expression was analyzed in myocardial and blood samples. From the studied microRNAs only miR-19b presented a direct correlation (p
